(R)-Simurosertib

TargetMol
Product Code: TAR-T12642
Supplier: TargetMol
CodeSizePrice
TAR-T12642-50mg50mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T12642-1mg1mg£128.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T12642-2mg2mg£149.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T12642-5mg5mg£222.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T12642-1mL1 mL * 10 mM (in DMSO)£228.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T12642-10mg10mg£282.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T12642-25mg25mg£458.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
(R)-Simurosertib is the (R)-enantiomer of Simurosertib. Simurosertib is an orally active, selective and ATP-competitive cell division inhibitor of cycle 7 (CDC7) kinase(IC50 of <0.3 nM).
CAS:
1330782-69-8
Formula:
C17H19N5OS
Molecular Weight:
341.43
Pathway:
Cell Cycle/Checkpoint
Purity:
0.98
SMILES:
Cc1n[nH]cc1-c1cc2[nH]c(nc(=O)c2s1)[C@H]1CC2CCN1CC2
Target:
CDK

References

1. K Iwai, et al. A novel CDC7-selective inhibitor TAK-931 with potent antitumor activity. European Journal of Cancer , 2016 , 69 (1) :S34.